verapamil has been researched along with ST Elevated Myocardial Infarction in 1 studies
Verapamil: A calcium channel blocker that is a class IV anti-arrhythmia agent.
verapamil : A racemate comprising equimolar amounts of dexverapamil and (S)-verapamil. An L-type calcium channel blocker of the phenylalkylamine class, it is used (particularly as the hydrochloride salt) in the treatment of hypertension, angina pectoris and cardiac arrhythmia, and as a preventive medication for migraine.
2-(3,4-dimethoxyphenyl)-5-{[2-(3,4-dimethoxyphenyl)ethyl](methyl)amino}-2-(propan-2-yl)pentanenitrile : A tertiary amino compound that is 3,4-dimethoxyphenylethylamine in which the hydrogens attached to the nitrogen are replaced by a methyl group and a 4-cyano-4-(3,4-dimethoxyphenyl)-5-methylhexyl group.
Excerpt | Relevance | Reference |
---|---|---|
"Verapamil was associated with lower incidence of angiographic MVO compared with SNP (13." | 2.84 | Efficacy and safety of intracoronary verapamil versus sodium nitroprusside for the prevention of microvascular obstruction during primary percutaneous coronary intervention for ST-segment elevation myocardial infarction. ( Abdelaziz, HK; Elkilany, W; Khalid, S; Saad, M; Sabet, S, 2017) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Abdelaziz, HK | 1 |
Elkilany, W | 1 |
Khalid, S | 1 |
Sabet, S | 1 |
Saad, M | 1 |
1 trial available for verapamil and ST Elevated Myocardial Infarction
Article | Year |
---|---|
Efficacy and safety of intracoronary verapamil versus sodium nitroprusside for the prevention of microvascular obstruction during primary percutaneous coronary intervention for ST-segment elevation myocardial infarction.
Topics: Coronary Angiography; Coronary Circulation; Coronary Vessels; Echocardiography; Electrocardiography; | 2017 |